Marizomib
- Generic Name
- Marizomib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H20ClNO4
- CAS Number
- 437742-34-2
- Unique Ingredient Identifier
- 703P9YDP7F
- Background
Marizomib has been used in trials studying the treatment of Cancer, Melanoma, Lymphoma, Glioblastoma, and Malignant Glioma, among others.
- Associated Conditions
- -
- Associated Therapies
- -
Glioblastoma Clinical Trials 2024: EMA, PDMA, FDA Approvals
DelveInsight's 'Glioblastoma Pipeline Insight, 2024' report details 190+ companies developing 200+ therapies, including Enzastaurin, Marizomib, VT1021, and ONC201, with insights on mechanism of action, route of administration, and market dynamics.
Related Clinical Trials:
How fish guts might play a role in future skin care products
Researchers found 22 molecules from fish gut bacteria with skin-brightening and anti-wrinkle properties, potentially for future cosmetics.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath